PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.782
https://www.valueinhealthjournal.com/article/S1098-3015(12)00847-9/fulltext
Title :
PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00847-9&doi=10.1016/j.jval.2012.03.782
First page :
A145
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
267